comparemela.com
Home
Live Updates
Almiralls Nine-month 2023 Results: : comparemela.com
Almirall's Nine-month 2023 Results:
BARCELONA, Spain, November 09, 2023--Almirall, S.A. (ALM), the global biopharmaceutical company based in Barcelona, has announced its 9M 2023.
Related Keywords
Austria
,
Spain
,
United States
,
Germany
,
United Kingdom
,
Hong Kong
,
Berlin
,
Barcelona
,
Comunidad Autonoma De Cataluna
,
Taiwan
,
Netherlands
,
Denmark
,
Italy
,
Macau
,
Switzerland
,
China
,
Spanish
,
Chinese
,
Omar Ram
,
Epimab Biotherapeutics
,
Astra Zeneca Covis
,
Eli Lilly
,
European Union
,
Corporate Communications
,
European Academy Of Dermatology
,
European Medicines Agency
,
Venereology Congress
,
Simcere Pharmaceutical Group
,
Spanish Stock Exchange
,
Committee For Medicinal Products Human Use
,
European Commission
,
Simcere Pharmaceutical Group For
,
Healthcare Products Regulatory Agency
,
Chinese National Medical Products Administration
,
European Association Of Dermatology
,
Net Sales
,
European Dermatology
,
New Drug Application
,
Astra Zeneca
,
Net Debt
,
Gallardo Piqu
,
European Association
,
Medicinal Products
,
Human Use
,
European Academy
,
Global Assessment
,
Eczema Area
,
Severity Index
,
Annual Fall Clinical Dermatology Conference
,
Large Field
,
Ichnos Science
,
Greater China
,
Mainland China
,
Fabs In Tandem Immunoglobulin
,
Noble Purpose
,
Safe Treatment
,
Psoriatic Disease
,
Real World Prospective Cohort Study
,
Patient Reported Outcomes
,
Tirbanibulin Effectiveness
,
Cutaneous Medicine
,
Lebrikizumab Is Maintained
,
Two Years
,
Clinical Dermatology
,
Almirall
,
Psoriasis
,
Plaque Psoriasis
,
Lebrikizumab
,
M
,
Uropean Academy Of Dermatology And Venereology
,
comparemela.com © 2020. All Rights Reserved.